| 30th Mar 2020 3:05 pm |
EQS |
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further |
| 27th Mar 2020 5:26 pm |
RNS |
Holding(s) in Company |
| 27th Mar 2020 9:17 am |
RNS |
Director Dealings |
| 27th Mar 2020 7:00 am |
RNS |
US Licencing Agreement with Eton Pharmaceuticals |
| 26th Mar 2020 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 26th Mar 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 25th Mar 2020 2:47 pm |
RNS |
Result of General Meeting and Issue of Equity |
| 20th Mar 2020 4:48 pm |
RNS |
Second Price Monitoring Extn |
| 20th Mar 2020 4:39 pm |
RNS |
Price Monitoring Extension |
| 6th Mar 2020 4:55 pm |
RNS |
Result of Placing and Notice of General Meeting |
| 6th Mar 2020 11:22 am |
RNS |
Proposed Placing |
| 5th Mar 2020 4:41 pm |
RNS |
Directorate Change |
| 28th Feb 2020 7:30 am |
EQS |
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow) |
| 25th Feb 2020 3:06 pm |
RNS |
Holding(s) in Company |
| 20th Feb 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 20th Feb 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 20th Feb 2020 11:00 am |
RNS |
Price Monitoring Extension |
| 17th Feb 2020 1:46 pm |
RNS |
Holding(s) in Company |
| 13th Feb 2020 7:00 am |
RNS |
US FDA Accepts NDA Application for Alkindi |
| 11th Feb 2020 7:00 am |
RNS |
Interim Results |
| 20th Jan 2020 7:00 am |
RNS |
Business and trading update |
| 13th Jan 2020 7:00 am |
RNS |
Notice of Interim Results |
| 13th Jan 2020 7:00 am |
RNS |
Holding(s) in Company |
| 10th Jan 2020 3:45 pm |
RNS |
Director Dealings and Issue of Equity |
| 10th Jan 2020 3:44 pm |
RNS |
Issue of Long-Term Incentive Plan awards |
| 16th Dec 2019 11:46 am |
RNS |
Director Dealings |
| 16th Dec 2019 7:00 am |
RNS |
Chronocort MAA Submitted in Europe |
| 2nd Dec 2019 2:28 pm |
RNS |
Share Option Exercise and Issue of Equity |
| 2nd Dec 2019 7:01 am |
RNS |
Holding(s) in Company |
| 2nd Dec 2019 7:00 am |
RNS |
Alkindi New Drug Application Submitted to US FDA |
| 26th Nov 2019 10:42 am |
RNS |
Director Dealings and Issue of Equity |
| 26th Nov 2019 7:15 am |
EQS |
Hardman & Co Research: Diurnal (DNL): Successful DITEST Phase I trial outcome |
| 21st Nov 2019 1:08 pm |
RNS |
Results of Annual General Meeting |
| 21st Nov 2019 7:00 am |
RNS |
AGM Statement |
| 20th Nov 2019 7:00 am |
RNS |
Successful outcome of testosterone clinical study |
| 8th Nov 2019 7:00 am |
RNS |
Vesting of LTIP awards |
| 5th Nov 2019 7:30 am |
EQS |
Hardman & Co Research: Diurnal (DNL): Approaching a number of near-term milestones |
| 21st Oct 2019 6:23 pm |
RNS |
Issue of Equity |
| 21st Oct 2019 1:09 pm |
RNS |
Director Dealings |
| 8th Oct 2019 11:26 am |
RNS |
Posting of Annual Report and AGM Notice |
